Lir Life Sciences Completes Design of a Comparative Animal Study Investigating Cell-Penetrating Peptide-Mediated Delivery of GLP/GIP-Based Obesity Therapies
Kane's revyve gel spray receives Health Canada approval
Microbix Biosystems rolls out QAPs for H3N2 flu testing
Hemostemix Inc. Announces FDA Pre-IND Meeting and NBPP of $960,000
SureNano Announces Closing of $1,250,000 Private Placement
BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS(TM) 2025
Medicenna Updates MDNA11 Clinical Trial Results at the ESMO-IO Congress 2025, Further Bolstering its Anti-Tumor Activity in Advanced Solid Tumors
Kane Biotech Receives Health Canada Approval for revyve(TM) Antimicrobial Wound Gel Spray
Microbix Launches New Products to Support H3N2 Flu Testing
Perimeter closes $3.55-million private placement
Safe Supply Streaming increases financing to $1-million
Ocumetics, Medicel modify lens delivery technology
Briacell phase 3 enrolment on track for H1 2026 readout
Perimeter Medical Imaging AI Closes C$3.6 Million Non-Brokered Private Placement
Diagnos Announces Closing of Oversubscribed $4 Million Brokered Private Placement Led by Centurion One Capital